Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AggreGuide A-100 ADP Assay Validation
NCT03111420Completed
- Sponsor
- Aggredyne, Inc.
- Start
- Jan 2017
- Primary completion
- Jun 2018
01
Overview
Open-label trial (3 arms), sponsored by Aggredyne, Inc. Primary endpoint: Platelet Activity Index at Day 7. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT03111420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03111420.